The impact of bladder symptoms on Relapsing Remitting Multiple Sclerosis patients’ Quality of Life- a pilot study.
1
Katowice, Poland, Department of Neurology, Faculty of Medical Sciences in Katowice, Medical University of Silesia in Katowice, Poland
2
Katowice, Poland, Students’ Scientific Association, Department of Neurology, Faculty of Medical Sciences in Katowice, Medical University of Silesia, Poland
Submission date: 2024-09-30
Final revision date: 2024-11-04
Acceptance date: 2024-11-09
Publication date: 2024-12-23
Corresponding author
Anna Walawska-Hrycek
Katowice, Poland, Department of Neurology, Faculty of Medical Sciences in Katowice, Medical University of Silesia in Katowice, Poland
Katowice, Poland, Department of Neurology, Faculty of Medical Sciences in Katowice, Medical University of Silesia in Katowice, Poland
Wiadomości Lekarskie 2024;77(11):2326-2331
KEYWORDS
TOPICS
ABSTRACT
Aim:
Bladder disorders are one of the most troubling symptoms of Multiple Sclerosis (MS), which impact patients quality of life (QoL). Therefore the aim of this pilot study was to assess this problem.
Material and methods:
47 patients (28 females and 19 males, aged 40,8±12,2 years; EDSS 3,2±1,9) diagnosed with Relapsing Remitting Multiple Sclerosis (RRMS) during disease modifying treatment (DMT) were enrolled to our study. Patients were asked to fill 8-item Actionable Bladder Symptoms Screening Tool (ABSST), Multiple Sclerosis Quality of Life Inventory (MSQLI) and King’s Health Questionnaire (KHQ).
Results:
Bladder problems were reported by 24/47 (51%) of patients, but only 7/24 (36,8%) were treated. The results of ABSST (2,3±1,5) and Incontinence Impact (II) domain of KHQ (40,3±20,5) indicated influence of the bladder disorders on patients QoL. Besides bladder control, the most important impact on QoL from MSQLI are fatigue and mental health issiues.
Conclusions:
Bladder symptoms in MS have significant impact on patients QoL, and therefore should be a part of clinical evaluation and must be actively treated.
Bladder disorders are one of the most troubling symptoms of Multiple Sclerosis (MS), which impact patients quality of life (QoL). Therefore the aim of this pilot study was to assess this problem.
Material and methods:
47 patients (28 females and 19 males, aged 40,8±12,2 years; EDSS 3,2±1,9) diagnosed with Relapsing Remitting Multiple Sclerosis (RRMS) during disease modifying treatment (DMT) were enrolled to our study. Patients were asked to fill 8-item Actionable Bladder Symptoms Screening Tool (ABSST), Multiple Sclerosis Quality of Life Inventory (MSQLI) and King’s Health Questionnaire (KHQ).
Results:
Bladder problems were reported by 24/47 (51%) of patients, but only 7/24 (36,8%) were treated. The results of ABSST (2,3±1,5) and Incontinence Impact (II) domain of KHQ (40,3±20,5) indicated influence of the bladder disorders on patients QoL. Besides bladder control, the most important impact on QoL from MSQLI are fatigue and mental health issiues.
Conclusions:
Bladder symptoms in MS have significant impact on patients QoL, and therefore should be a part of clinical evaluation and must be actively treated.
Share
RELATED ARTICLE
| eISSN: | 2719-342X |
| ISSN: | 0043-5147 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
